NEW YORK (GenomeWeb News) — Contract research company BioFocus DPI said today that it has installed a Waters Xevo TQ Mass Spectrometer for use in its drug metabolite discovery services for pharmaceutical clients.

Using the Xevo alongside Waters' UltraPerformance liquid chromatography technology will increase the lab’s throughput and "allows more accurate measurements to both quantify and confirm the identity of metabolites in a wide range of biological fluids and tissues," enabling an increased likelihood of metabolite detection, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.

The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.

A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.

National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.

Mar
05
Sponsored by
SomaLogic

In this live webcast, Robert Gerszten of Massachusetts General Hospital will describe an ongoing project that is integrating metabolic and proteomic profiling to gain a better understanding of cardiometabolic disease.